It was learned that Xingtong Medical announced the completion of a new round of financing. This funding will support Starchild to expand domestic and international markets and accelerate the development of new products. Starchild Medical is a company engaged in innovative immunodiagnostic platform systems. Maixing Investment invested in Starchild Medical for the first time in 2015 and has continued to invest in the past few years.
In recent years, Xingtong Medical has achieved rapid development in the Chinese immunodiagnosis market, and its sales channels have spread to most provinces and cities nationwide. The world-leading Pylon 3D automatic immunoassay analyzer has been installed in hundreds of large and medium-sized hospitals. Starchild's PCT, BNP, cTnI and other reagents can be comparable in performance and quality to international brands.
After completing the ISO13485 quality system certification, Star Instruments Medical's instruments and reagents have obtained CE certification, opening the door to enter the international market. In addition, Xingtong is actively preparing to apply for a FDA listing license to enter the US market as soon as possible.
So far, Xingtong Medical has obtained nearly 50 invention patents in the United States, China, Europe, Japan and other regions, and established a strong intellectual property protection barrier for core technologies.
Li Xin, managing director of Maixing Investment, said: "We have been growing with the company for many years and deeply agree with CEO Tan Hongbo's philosophy and initial intention. I have seen the company's step-by-step business progress and outstanding achievements all the way, complicated in the Chinese IVD market. It is especially valuable under the environment. It is these unique values ​​that enable Maixing Investment to continue to invest in Starchildren."
Dr. Tan Hong, CEO of Xingtong Medical, said: "In the period when the investment climate has changed, I am very grateful to the new and old investors for their trust and support to Starchild. At the same time, this also proves that the capital market recognizes the achievements of Starchildren and recognizes Starchild team. We will continue to work hard to build Star Children into the world's leading diagnostic technology company."
It is a professional supplier of Caine Product Ropivacaine , Lidocaine , tetracaine , Bupivacaine . It has absolute advantage because of strong research strength, modern management system and high-quality marketing team.
Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world.
For customer`s needs, OEM service is also acceptable. If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.
Caine Product, Ropivacaine, Lidocaine, tetracaine
Xi'an Henrikang Biotech Co.,Ltd , https://www.xianhenrikang.com